Civis Analytics Launches COVID-19 Vaccine Intelligence Platform to Boost Vaccination Rates

By Bruce Harpham Saturday, April 24, 2021

Civis Analytics, a data science company based in Chicago, has launched a vaccine product to help with vaccine outreach and planning. The business platform provides critical public health metrics and analytics so that governments and other organizations can better cooperate. The Vaccine Outreach Intelligence Center (VOIC) is a new implementation of a prior product, Census Intelligence Center, created by the data science company. The state of Michigan previously used the Census product.

Person using smart phone, clicking on vaccine app.

Civis Analytics Data Highlights Vaccine Challenges

In March 2021, the company released research on the impact of COVID-19 in the US with funding from the Bill & Melinda Gates Foundation. The survey found that vaccination rates significantly vary by race. While 31% of white adults have been vaccinated, only 19.9% of Hispanic adults have been vaccinated. Furthermore, the company found that more than 30% of US adults show some level of vaccine hesitancy. These insights may prompt governments to work with Civis Analytics to customize vaccine distribution and outreach campaigns.

Civis Analytics also explored the economic and business impact of the pandemic. The company found that 38% of US adults say their income has decreased since the start of the pandemic. Additionally, the data business found that 12% of American adults have voluntarily left a job or reduced their work hours to care for family members.

Civis Analytics Researches Vaccine Messaging

The data company has also conducted research on which messaging strategies convince people to get a COVID-19 vaccine. Overall, the business found that a message with "a tragic personal story was the most effective approach at driving intent to get vaccinated." The personal story message increased intent to seek a vaccine by 5%. In contrast, messages that stress economic recovery or community benefits have a meaningful chance of creating a negative backlash. The company developed these insights after running a survey with more than three respondents.

The Business Helps the Drive to Herd Immunity

The data company has the chance to make a difference in herd immunity in defeating the COVID-19 virus. According to the CDC, herd immunity is a "situation in which a sufficient proportion of a population is immune to an infectious disease (through vaccination and/or prior illness) to make its spread from person to person unlikely." The proportion of the population that needs to be immune varies depending on the disease. For example, the Mayo Clinic states that 94% of the population needs to be immune to measles to prevent the spread of that illness.

If the measles herd immunity level was required to protect against COVID-19, approximately 308 million Americans (i.e., 94% of the country’s population as of 2019) would require immunity. Achieving that high level of immunity in the population quickly creates demand for accurate tracking.

Civis Analytics Data Reveals Changing Consumer Preferences

The business has also explored shifting business trends caused by the pandemic. For example, the data business found that one-third of Americans plan to travel more within the US after the pandemic ends. Also, the business found that Americans earning under $50,000 per year planned to reduce their gift spending by more than 10% in the 2020 holiday season.

Civis Analytics has more than 180 employees and has raised over $40 million in funding from investors.

About the Author


Headshot of Bruce Harpham

Bruce Harpham is an author and marketing consultant based in Canada. His first book, "Project Managers At Work," shared real-world success lessons from NASA, Google, and other organizations. His articles have been published in CIO.com, InfoWorld, Canadian Business, and other organizations. Visit BruceHarpham.com for articles, interviews with tech leaders, and updates on future books.

Related Articles